| Signal Transduction and Targeted Therapy | Q1 | 17.00 | 224 | 1 |
| Cell Metabolism | Q1 | 15.00 | 391 | 1 |
| Physiological Reviews | Q1 | 11.00 | 417 | 1 |
| Science | Q1 | 10.00 | 1433 | 1 |
| Psychological Bulletin | Q1 | 8.00 | 396 | 1 |
| Cell Research | Q1 | 6.00 | 244 | 1 |
| JAMA Psychiatry | Q1 | 5.00 | 429 | 5 |
| Journal of Experimental Medicine | Q1 | 5.00 | 513 | 1 |
| Molecular Psychiatry | Q1 | 4.00 | 274 | 4 |
| Cancer Research | Q1 | 4.00 | 522 | 2 |
| Nature Communications | Q1 | 4.00 | 634 | 2 |
| Clinical Cancer Research | Q1 | 4.00 | 405 | 1 |
| American Journal of Psychiatry | Q1 | 4.00 | 418 | 1 |
| Proceedings of the National Academy of Sciences of the United States of America | Q1 | 3.00 | 929 | 2 |
| Advanced Science | Q1 | 3.00 | 253 | 1 |
| Acta Pharmaceutica Sinica B | Q1 | 3.00 | 146 | 1 |
| Cell Reports | Q1 | 3.00 | 265 | 1 |
| Journal of Neuroinflammation | Q1 | 3.00 | 189 | 1 |
| BMC Medicine | Q1 | 2.00 | 214 | 3 |
| Translational Psychiatry | Q1 | 2.00 | 150 | 3 |
| Brain, Behavior, and Immunity | Q1 | 2.00 | 221 | 2 |
| Schizophrenia Bulletin | Q1 | 2.00 | 236 | 1 |
| JCI Insight | Q1 | 2.00 | 144 | 1 |
| British Journal of Psychiatry | Q1 | 2.00 | 276 | 1 |
| British Journal of Pharmacology | Q1 | 2.00 | 262 | 1 |
| Neurobiology of Disease | Q1 | 2.00 | 206 | 1 |
| Psychological Medicine | Q1 | 2.00 | 262 | 1 |
| Acta Psychiatrica Scandinavica | Q1 | 2.00 | 182 | 1 |
| International Journal of Molecular Sciences | Q1 | 1.00 | 365 | 4 |
| Brain, Behavior, and Immunity - Health | Q1 | 1.00 | 44 | 2 |
| Frontiers in Cellular and Infection Microbiology | Q1 | 1.00 | 156 | 2 |
| Frontiers in Immunology | Q1 | 1.00 | 294 | 2 |
| Journal of Acquired Immune Deficiency Syndromes (1999) | Q1 | 1.00 | 180 | 1 |
| Current Neuropharmacology | Q1 | 1.00 | 125 | 1 |
| Biology of Sex Differences | Q1 | 1.00 | 76 | 1 |
| Depression and Anxiety | Q1 | 1.00 | 180 | 1 |
| BMC Psychiatry | Q1 | 1.00 | 164 | 1 |
| International Journal of Tryptophan Research | Q1 | 1.00 | 38 | 1 |
| Neurochemical Research | Q1 | 1.00 | 143 | 1 |
| Nutrients | Q1 | 1.00 | 279 | 1 |
| Microorganisms | Q1 | 1.00 | 139 | 1 |
| Antioxidants | Q1 | 1.00 | 169 | 1 |
| Neuropsychobiology | Q1 | 1.00 | 97 | 1 |
| Progress in Neuro-Psychopharmacology and Biological Psychiatry | Q1 | 1.00 | 165 | 1 |
| AIDS | Q1 | 1.00 | 237 | 1 |
| Psychopharmacology | Q1 | 1.00 | 224 | 1 |
| Biomolecules | Q1 | 1.00 | 161 | 1 |
| Journal of Immunology | Q1 | 1.00 | 433 | 1 |
| FASEB Journal | Q1 | 1.00 | 320 | 1 |
| Scientific Reports | Q1 | | 382 | 1 |
| Frontiers in Psychology | Q1 | | 241 | 1 |
| Frontiers in Neuroscience | Q2 | 1.00 | 186 | 1 |
| Frontiers in Cellular Neuroscience | Q2 | 1.00 | 152 | 1 |
| Metabolic Brain Disease | Q2 | | 87 | 1 |
| Indian Journal of Psychological Medicine | Q2 | | 50 | 1 |
| Biochemistry and Biophysics Reports | Q2 | | 56 | 1 |
| Frontiers in Neurology | Q2 | | 132 | 1 |
| European Journal of Neuroscience | Q2 | | 238 | 1 |
| Molecular Medicine Reports | Q2 | | 106 | 1 |
| Cellular Physiology and Biochemistry | Q3 | | 123 | 1 |